10.20% p.a. Multi Barrier Reverse Convertible
Novartis, Partners Group, Roche, UBS
Valor
140863369
SIX Symbol
PRHRCH
ISIN
CH1408633696
Currency
CHF
Bid (indicative)
{{ brochure.product.productFeed.bid | number:2 }}{{ brochure | quotingPercentage: brochure.product.productFeed.bid }}
250'000.00
Ask (indicative)
{{ brochure.product.productFeed.ask | number:2 }}{{ brochure | quotingPercentage: brochure.product.productFeed.ask }}
250'000.00
Price on
{{ brochure.product.productFeed.date | timeFormat }}
{{ brochure.product.productFeed.date | dateShortFormat }}
Identifiers
140863369
CH1408633696
PRHRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Figures
8.06%
-3.54%
Parameters
Raiffeisen Switzerland B.V., Amsterdam, The Netherlands
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
10.20% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
CHF 5'000.00
CHF
CHF 250'000.00
CHF 250'000.00
Listed
No
Life Cycle
1.25 Years
07 Feb 2025
14 Feb 2025
14 Feb 2025
26 Feb 2025
26 Feb 2025
19 May 2026
26 May 2026
Barrier
65.00%
Continuous barrier observation (american)
14 Feb 2025 - 19 May 2026
No
28.74%
Product Specific Features
100.00%
Performance
Market Price Initial Fixing Level Barrier Level Distance to Barrier Strike Level Distance to Strike
Novartis
{{ underlyings['67108969'].currency }} {{ underlyings['67108969'].underlyingFeed.spot | number:2 }}
CHF 95.37 CHF 61.99 36.78% CHF 95.37 2.74%
Partners Group
{{ underlyings['67109101'].currency }} {{ underlyings['67109101'].underlyingFeed.spot | number:2 }}
CHF 1'422.50 CHF 924.63 28.74% CHF 1'422.50 -9.63%
Roche
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
CHF 294.50 CHF 191.43 35.11% CHF 294.50 0.17%
UBS
{{ underlyings['67108976'].currency }} {{ underlyings['67108976'].underlyingFeed.spot | number:2 }}
CHF 30.18 CHF 19.62 29.79% CHF 30.18 -8.02%
Cannot load the chart. Please try again later
Coupons
Payment Date Amount
26 May 2025 2.55%
26 Aug 2025 2.55%
26 Nov 2025 2.55%
26 Feb 2026 2.55%
26 May 2026 2.55%
Early Redemption
Observation Date Redemption Amount
19 Aug 2025 100.00%
19 Nov 2025 100.00%
19 Feb 2026 100.00%
Novartis
Cannot load the chart. Please try again later
Novartis
{{ underlyings['67108969'].currency }} {{ underlyings['67108969'].underlyingFeed.spot | number:2 }}
NOVN SW
CHF
CHF 95.37
52.4274
CHF 61.9905
36.7831%
CHF 95.37
2.7432%
SIX Swiss Exchange AG
Partners Group
Cannot load the chart. Please try again later
Partners Group
{{ underlyings['67109101'].currency }} {{ underlyings['67109101'].underlyingFeed.spot | number:2 }}
PGHN SW
CHF
CHF 1'422.50
3.5149
CHF 924.625
28.738%
CHF 1'422.50
-9.6339%
SIX Swiss Exchange AG
Roche
Cannot load the chart. Please try again later
Roche
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
ROG SW
CHF
CHF 294.50
16.9779
CHF 191.425
35.1102%
CHF 294.50
0.1695%
SIX Swiss Exchange AG
UBS
Cannot load the chart. Please try again later
UBS
{{ underlyings['67108976'].currency }} {{ underlyings['67108976'].underlyingFeed.spot | number:2 }}
UBSG SW
CHF
CHF 30.18
165.6726
CHF 19.617
29.7888%
CHF 30.18
-8.0172%
SIX Swiss Exchange AG